Overall, these findings demonstrated that hypoxic exosomal UCA1 may enhance angiogenesis and tumor growth in PC via the miR-96-5p/AMOTL2/ERK1/2 axis and so could be a novel therapeutic target for PC (Figure 4) (13, 98). The gene discussed is AMOTL2; the disease is pachyonychia congenita.